Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutch patient without travel history abroad, August 2015 by Bathoorn, E. et al.
  
 University of Groningen
Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutch patient without
travel history abroad, August 2015





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Bathoorn, E., Rossen, J. W., Lokate, M., Friedrich, A. W., & Hammerum, A. M. (2015). Isolation of an NDM-
5-producing ST16 Klebsiella pneumoniae from a Dutch patient without travel history abroad, August 2015.
Eurosurveillance, 20(41). https://doi.org/10.2807/1560-7917.ES.2015.20.41.30040
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Isolation of an NDM-5-producing ST16 Klebsiella 
pneumoniae from a Dutch patient without travel history 
abroad, August 2015
E Bathoorn 1 , JW Rossen 1 , M Lokate 1 , AW Friedrich 1 , AM Hammerum 2 
1. Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the 
Netherlands
2. Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark
Correspondence: Erik Bathoorn (d.bathoorn@umcg.nl)
Citation style for this article: 
Bathoorn E, Rossen JW, Lokate M, Friedrich AW, Hammerum AM. Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutch patient without travel 
history abroad, August 2015. Euro Surveill. 2015;20(41):pii=30040. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.41.30040 
Article submitted on 02 October 2015 / accepted on 14 October 2015 / published on 15 October 2015
A New Delhi Metallo-beta-lactamase-5 (NDM-5)-
producing ST16 Klebsiella pneumoniae strain was iso-
lated from a Dutch patient in a long-term care facility 
without recent travel history abroad. Core genome 
multilocus sequence typing (cgMLST) revealed that 
the Dutch isolate was clonally related to isolates 
detected in four patients in Denmark in 2014. Public 
health experts and clinicians need to be informed; 
repetitive screening may be needed in patients with-
out known risk factors for carbapenemases-producing 
Enterobacteriaceae who have undergone antibiotic 
treatment.
Here we report of a New Delhi Metallo-beta-lactamase-5 
(NDM-5)-carrying ST16 Klebsiella pneumoniae, isolated 
from a hospitalised patient in the Netherlands, with 
no recent history of travel abroad. Analysis by core 
genome multilocus sequence typing (cgMLST) based 
on the core genome sequence of the isolate, showed 
that it is clonally related to four recently reported iso-
lates cultured from four patients in two hospitals in 
Denmark, in 2014 [1].
Background
NDM is a carbapenemase that has been detected for 
the first time in a Swedish patient returning from New 
Delhi in 2008 [2]. In the first years thereafter, introduc-
tion of NDM-producing isolates in European hospitals 
was associated with returning travellers from India and 
Pakistan [3]. NDM-producing Enterobacteriaceae are 
rapidly dispersing over the world, and cases without 
any epidemiolgical links to the Indian subcontinent 
have been reported [4]. Reports on detection of NDM in 
environmental samples and in the food chain are wor-
risome, in particular since this might implicate spread 
of these resistance genes in the community [5,6]. In 
northern and western Europe, however, identification 
of patients with NDM-producing Enterobacteriaceae is 
still rare [7].
Currently, nine types of NDMs have been detected, of 
which NDM-1 is the most prevalent type [8]. NDM-5 has 
been isolated for the first time in the United Kingdom 
in 2011 from a patient returning from India [9]. Cases of 
NDM-5-carrying Enterobacteriaceae are sporadic. Some 
unrelated cases have been described, for instance 
three cases in Algeria and a case in Spain, with no 
recent history of travel abroad [10,11]. The identification 
of unrelated cases colonised with the same of NDM-5-
producing K. pneumoniae ST16 clone in two countries 
with low prevalence, may be cause for concern.
Case description
A Dutch patient in their 50s suffering from spinal 
cord injury had been admitted for rehabilitation in 
a long-term care facility in a northern region of the 
Netherlands. Upon admission in August 2015 (day 0), 
swab cultures taken from throat and rectum were neg-
ative for carbapenem-resistant Gram-negatives. The 
patient was treated upon admission with ceftriaxone 
2 gr once per day for seven days, for an infection.
On day 10, an NDM-5-producing K. pneumoniae was 
cultured from a rectal swab taken as part of routine 
screening. Antibiogram based on automated suscep-
tibility testing (VITEK2, bioMerieux, Marcy l’Etoile, 
France) and E-tests (AB Biodisk, Mannheim, Germany) 
showed increased minimum inhibitory concentrations 
(MICs) to meropenem and imipenem, and susceptibility 
to gentamicin, fosfomycin, and colistin (Table).
Whole genome sequencing, de novo assembly, and 
assessment of multilocus sequence typing (MLST), 
cgMLST, and resistome were performed as described 
previously [12,13]. The strain harboured beta-lactam 
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genes blaNDM-5, blaCTX-M-15, blaSHV-1, blaOXA-1, and blaTEM-1b; 
non-beta-lactam acquired resistance genes included 
strB, strA, aac(6”)lb-cr, QnrB66, fosA, catB3, sul2, 
tet(A), and dfrA14.
The patient was isolated and their room was cleaned 
and disinfected once a day. Throat and rectum swabs 
were taken twice a week from all 25 patients on the 
ward during the following three weeks. Pooled sam-
ples from rectum and throat were tested both by direct 
PCR (Check-direct CPE, Check-points, Wageningen, the 
Netherlands), and incubated in Brain-Heart Infusion 
broth with 0.25 mg/L ceftriaxone. The broth was sub-
sequently cultured on combination Iso-Sensitest agar 
plates containing ceftriaxone, ceftazidime, tobramycin, 
or piperacillin/tazobactam (Mediaproducts, Groningen, 
the Netherlands). All patients were screened likewise 
upon admission or discharge for a period of three 
weeks. Ten patients who had been hospitalised on 
the same ward from day 0, and had already been dis-
charged, were contacted and invited to the ward for 
taking cultures. Among 45 patients investigated, no 
additional cases have been detected as at 15 October 
2015.
To search for the origin of the NDM-positive K. pneu-
moniae strain, environmental cultures were taken. 
All healthcare workers on the ward received a ques-
tionnaire on the following risk factors: recent stay 
in a foreign hospital as patient or worker, or being 
colonised previously with carbapenemase-producing 
Enterobacteriaceae (CPE). We did not advise to take 
cultures from healthcare workers because the Dutch 
infection control guidelines recommend only to screen 
healthcare workers in case of ongoing transmission 
after implementation of outbreak control measures 
[14]. We did not identify any likely origins through 
these investigations.
Literature was searched for common sources of NDM-
5-producing Enterobacteriaceae. A recently published 
report on a Danish cluster of four patients with NDM-
5-producing K. pneumoniae clones presented a simi-
lar resistome to our case (blaNDM-5, blaCTX-M-15, blaSHV-1, 
blaOXA-1, and blaTEM-1b) [1]. Sequences of the Danish iso-
lates were compared with the isolate from the Dutch 
case. All isolates belonged to ST16. The results of 
cgMLST analysis using a typing scheme described by 
Bialek-Davenet et al. [15] showed no allelic mismatches 
between our isolate and the Danish isolates (NCBI 
BioProject ID PRJNA285138). When comparing with ref-
erence strain K. pneumoniae 1084 (GenBank accession 
number CP003785), we found 491 allelic mismatches 
(Figure). Thus, the isolate of our patient is clonally 
related to the Danish isolates.
Discussion
We report the sporadic detection of an NDM-5-producing 
K. pneumoniae from a Dutch patient with no risk fac-
tors for acquisition. The origin of the strain is unknown. 
Similar cases have been presented in Denmark with 
clonally related isolates. There were no known direct 
epidemiological links between the Danish patients and 
our case: the Danish positive cases did not travel to 
the Netherlands, and in our long-term care facility, no 
Danish patients were hospitalised during the past year. 
Figure 
Minimal spanning tree of the four Danish NDM-5-
producing ST16 Klebsiella pneumoniae isolates, the Dutch 








NDM: New Delhi Metallo-beta-lactamase.
Sequences of core genome genes of Danish (DK-) isolates, the 
Dutch (NL-) isolate, and reference strain K. pneumoniae 1084 
(GenBank accession number CP003785) were compared.
The tree is based on 634 columns, pairwise ignoring missing 
values. Number of allelic mismatches is presented.
Antimicrobial agent MIC (mg/L)a Interpretationa
Piperacillin/tazobactam ≥ 128 S
Cefotaximeb 16 R
Ceftazidime ≥ 64 R
Cefepime ≥ 64 R
Meropenemb 6 I
Imipenem ≥ 16 R
Ciprofloxacin ≥ 64 R
Gentamicin ≤ 1 S
Tobramycin ≥ 64 R
Trimethoprim-sulfamethoxazole ≥ 320 R
Colistin ≤ 0.5 S
Tigecyclin b 2 I
Fosfomycin b 3 S
Table
Antimicrobial minimum inhibitory concentrations for 
the NDM-5-producing Klebsiella pneumoniae isolate in a 
Dutch patient in a long-term care facility, August 2015
MIC: minimum inhibitory concentration; I: intermediate; R: 
resistant; S: susceptible.
a According to the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) guidelines.
b Measured by E-test.
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Unknown links or a common source may be the reason 
for the clonality of this rare isolate.
Another explanation might be that the clonal strains 
have been acquired from a foodborne source. 
Escherichia coli carrying blaNDM-5, blaCTX-M and blaTEM 
have been reported as cause of mastitis in cows, sug-
gesting that blaNDM-5-carrying plasmids might enter the 
food chain. Moreover, contamination of retail chicken 
meat with K. pneumoniae producing a combination of 
NDM, CTX-M-15, TEM, and SHV-1 has recently been 
reported [16]. Typing of blaNDM, plasmid, and MLST 
of these isolates may reveal a link with a foodborne 
source.
K. pneumoniae ST16 is a highly prevalent type caus-
ing nosocomial infections [17]. It is unsure whether 
this ST16 clone is newly introduced, or whether this 
clone was already present in our region, and has now 
acquired an NDM-5-carrying plasmid. We anticipate a 
full study, which will assess the relation between the 
NDM-5-producing isolates and the epidemic CTX-M-15-
producing K. pneumoniae ST16 isolates in our region, 
and possible links with the food chain. Since our case 
was detected by chance and we did not identify any 
routes of transmission, further cases may be found in 
the Netherlands or elsewhere. We contacted national 
reference centers in Europe to find cases retrospec-
tively, and to alert them about potential future cases. 
Finally, our case suggests that it might be necessary, 
under specific conditions, to screen for CPE also in 
patients who do not have a recent history of travel to 
a CPE-endemic country, and that diagnostics excluding 
CPE at admission, should be repeated if patients are 
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